Pharmacotherapy for obesity

被引：11

作者：

Hensrud, DD

机构：

[1] Mayo Clin & Mayo Fdn, Div Prevent Med, Rochester, MN 55905 USA

[2] Mayo Clin & Mayo Grad Sch Med, Div Prevent Med, Rochester, MN 55905 USA

[3] Mayo Clin & Mayo Grad Sch Med, Div Metab Endocrinol & Nutr, Rochester, MN 55905 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2000年 / 84卷 / 02期

关键词：

D O I：

10.1016/S0025-7125(05)70231-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article discusses former and current medications used to treat obesity, reviews efficacy and safety data for current medications, and suggests clinical guidelines for their use.

引用

页码：463 / +

页数：15

共 36 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2]

[Anonymous], [No title captured]

[3]

[Anonymous], INT J OBESITY RELATE

[4] Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine [J].

Apfelbaum, M ;

Vague, P ;

Ziegler, O ;

Hanotin, C ;

Thomas, F ;

Leutenegger, E .

AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) :179-184

[5]

ASTRUP A, 1992, INT J OBESITY, V16, P269

[6] Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].

Bonow, RO ;

Carabello, B ;

de Leon, AC ;

Edmunds, LH ;

Fedderly, BJ ;

Freed, MD ;

Gaasch, WH ;

McKay, CR ;

Nishimura, RA ;

O'Gara, PT ;

O'Rourke, RA ;

Rahimtoola, SH ;

Ritchie, JL ;

Cheitlin, MD ;

Eagle, KA ;

Gardner, TJ ;

Garson, A ;

Gibbons, RJ ;

Russell, RO ;

Ryan, TJ ;

Smith, SC .

CIRCULATION, 1998, 98 (18) :1949-1984

[7] Sibutramine produces dose-related weight loss [J].

Bray, GA ;

Blackburn, GL ;

Ferguson, JM ;

Greenway, FL ;

Jain, AK ;

Mendel, CM ;

Mendels, J ;

Ryan, DH ;

Schwartz, SL ;

Scheinbaum, ML ;

Seaton, TB .

OBESITY RESEARCH, 1999, 7 (02) :189-198

[8] USE AND ABUSE OF APPETITE-SUPPRESSANT DRUGS IN THE TREATMENT OF OBESITY [J].

BRAY, GA .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) :707-713

[9] Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment [J].

Cannistra, LB ;

Cannistra, AJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :771-771

[10]

Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1061

← 1 2 3 4 →